BEAM - Beam Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2025-08-05    (Delayed quote data   2025-06-30)
Last
 17.01		 Change
 ⇑ +0.21   (+1.25%)		 Volume
  1,531,514
Open
 17.00		 High
 17.73		 Low
 16.86
8EMA (Daily)
 16.96		 40EMA (Daily)
 17.60		 50EMA (Daily)
 17.97		 STO (Daily)
 26.315		 MACD Hist (Daily)
 0.088
8EMA (Weekly)
 17.371		 40EMA (Weekly)
 21.70		 50EMA (Weekly)
 22.53		 STO (Weekly)
 31.776		 MACD Hist (Weekly)
 -0.082
Company Profile
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com